← Open Payments lookup

JANICE CUNNINGHAM: Open Payments

NPI 1700151651 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,134 in 79 payments from 12 companies in 2025. Trend: 2023 $1,233 · 2024 $1,203 · 2025 $1,134

Food & beverage: $1,134
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$302
ABBVIE INC.14$171
Janssen Pharmaceuticals, Inc12$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$112
Neurocrine BioSciences, Inc.6$93
Alkermes, Inc.4$80
Axsome Therapeutics, Inc.4$61
Teva Pharmaceuticals USA, Inc.3$60
E.R. Squibb & Sons, L.L.C.3$51
Gilead Sciences, Inc.1$22

Products named: REXULTI, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, INGREZZA, INVEGA SUSTENNA, ARISTADA, Auvelity.

Industry payments across NE — which companies pay providers there.